Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab.

被引:0
作者
Gigi, E. [1 ]
Georgiou, T. [1 ]
Sarantopoulos, A. [2 ]
Mougiou, D. [3 ]
Boura, P. [2 ]
Raptopoulou-Gigi, M. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Hippokratio Hosp, Dept Internal Med 2, Liver Unit,Med Sch, GR-54006 Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Clin Immunol Unit, Dept Internal Med 2, Hippokratio Hosp,Med Sch, GR-54006 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Dept Clin Microbiol, Sch Med, GR-54006 Thessaloniki, Greece
关键词
HBV reactivation; rituximab; rheumatoid arthritis; monoclonal antibodies; VIRUS HBV REACTIVATION; PREVENTION; MANAGEMENT; CHEMOTHERAPY; STATEMENT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis B virus (HBV) can still be found within the hepatocytes after its clearance and the control of viral replication depends on the immune response. However during immunosuppression, seroconversion of HBsAg has been described followed by disease reactivation. Hepatitis B virus reactivation represents an emerging cause of liver disease in patients undergoing treatment with biologic agents and in particular, by the use of rituximab (anti-CD20) and alemtuzumab (anti-CD52) that cause profound and long-lasting immunosuppression. We describe a case of a 64-year old female patient with rheumatoid arthritis and resolved HBV infection, who experienced a severe hepatitis B reactivation after the administration of rituximab.
引用
收藏
页码:91 / 93
页数:3
相关论文
共 13 条
  • [1] Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
    Buch, Maya H.
    Smolen, Josef S.
    Betteridge, Neil
    Breedveld, Ferdinand C.
    Burmester, Gerd
    Doerner, Thomas
    Ferraccioli, Gianfranco
    Gottenberg, Jacques-Eric
    Isaacs, John
    Kvien, Tore K.
    Mariette, Xavier
    Martin-Mola, Emilio
    Pavelka, Karel
    Tak, Paul P.
    van der Heijde, Desiree
    van Vollenhoven, Ronald F.
    Emery, Paul
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 909 - 920
  • [2] Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
    Evens, A. M.
    Jovanovic, B. D.
    Su, Y. -C.
    Raisch, D. W.
    Ganger, D.
    Belknap, S. M.
    Dai, M. -S.
    Chiu, B. -C. C.
    Fintel, B.
    Cheng, Y.
    Chuang, S. -S.
    Lee, M. -Y.
    Chen, T. -Y.
    Lin, S. -F.
    Kuo, C. -Y.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (05) : 1170 - 1180
  • [3] Is Screening for Hepatitis B and Hepatitis C Useful in Patients with Recent-Onset Polyarthritis? The ESPOIR Cohort Study
    Guennoc, Xavier
    Narbonne, Valerie
    Jousse-Joulin, Sandrine
    Devauchelle-Pensec, Valerie
    Dougados, Maxime
    Daures, Jean Pierre
    Saraux, Alain
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (07) : 1407 - 1413
  • [4] Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
    Koo, Yu Xuan
    Tay, Matthew
    Teh, Yii Ean
    Teng, David
    Tan, Daniel S. W.
    Tan, Iain B. H.
    Tai, David W. M.
    Quek, Richard
    Tao, Miriam
    Lim, Soon Thye
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1219 - 1223
  • [5] Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
    Kusumoto, Shigeru
    Tanaka, Yasuhito
    Ueda, Ryuzo
    Mizokami, Masashi
    [J]. JOURNAL OF GASTROENTEROLOGY, 2011, 46 (01) : 9 - 16
  • [6] Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
    Lalazar, Gadi
    Rund, Deborah
    Shouval, Daniel
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (05) : 699 - 712
  • [7] Hepatitis B reactivation after chemotherapy: two decades of clinical research
    Lau, George K. K.
    [J]. HEPATOLOGY INTERNATIONAL, 2008, 2 (02) : 152 - 162
  • [8] Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    Lavanchy, D
    [J]. JOURNAL OF VIRAL HEPATITIS, 2004, 11 (02) : 97 - 107
  • [9] Current trends in management of hepatitis B virus reactivation in the biologic therapy era
    Mastroianni, Claudio M.
    Lichtner, Miriam
    Citton, Rita
    Del Borgo, Cosmo
    Rago, Angela
    Martini, Helene
    Cimino, Giuseppe
    Vullo, Vincenzo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (34) : 3881 - 3887
  • [10] Epidemiology and natural history of hepatitis B
    McMahon, BJ
    [J]. SEMINARS IN LIVER DISEASE, 2005, 25 : 3 - 8